Thermalsole und Schwefelbad Bentheim GmbH

At Thermalsole und Schwefelbad Bentheim GmbH, a major part of the clinical research portfolio focuses on immune system diseases and skin and connective tissue diseases, especially atopic dermatitis and related eczema conditions. These studies are designed to evaluate new treatment options, compare them with existing therapies, and better understand long-term control of itching and skin inflammation.

• Moderate-to-severe atopic dermatitis and chronic eczema
• Testing new therapies and comparing them with established treatments
• Long-term safety, symptom control, and improvement in skin symptoms

The site’s work in this area includes both adult and pediatric populations, reflecting a broad effort to improve care across age groups.

Another important research area covers psoriasis and psoriatic arthritis, with trials aimed at both skin symptoms and joint-related disease activity. These studies generally assess whether newer therapies can improve disease control, reduce flare-ups, and offer better outcomes for people living with persistent inflammatory disease.

• Plaque psoriasis, pustular psoriasis, and palmoplantar pustulosis
• Psoriatic arthritis and related inflammatory symptoms
• Evaluating treatment effectiveness and symptom improvement

This research area highlights the clinic’s strong focus on immune-mediated inflammatory conditions and practical treatment advances.

The clinical studies also include hormonal diseases and hair-related disorders, especially alopecia areata and other forms of hair loss. Research at the site is centered on finding treatments that can support hair regrowth, maintain response over time, and improve quality of life for patients affected by visible hair loss.

• Alopecia areata in children, adolescents, and adults
• Female androgenetic alopecia and other hair loss conditions
• Testing therapies intended to stimulate regrowth and sustain benefit

These studies reflect a growing interest in both the medical and psychosocial impact of chronic hair disorders.

Research at the Klinisches Studienzentrum also includes vitiligo, particularly non-segmental forms that affect skin pigmentation. The studies are focused on evaluating whether emerging therapies can help restore pigment, improve visible skin changes, and provide durable disease control.

• Non-segmental vitiligo in adults and adolescents
• Improving repigmentation and disease stability
• Assessing treatment benefit in a chronic visible skin condition

This area adds to the site’s broader expertise in inflammatory and immune-related skin disease research.

A further focus is on conditions marked by severe itching and recurrent skin symptoms, including chronic spontaneous urticaria, prurigo nodularis, and chronic pruritus-related disorders. These trials aim to improve itch relief, reduce skin lesions, and evaluate how well new treatments can control symptoms that strongly affect daily life.

• Chronic spontaneous urticaria and chronic pruritus
• Prurigo nodularis and lichen simplex chronicus
• Measuring symptom relief and overall treatment effectiveness

At Thermalsole und Schwefelbad Bentheim GmbH, this field supports research into better symptom management for patients with highly burdensome skin disease.

The site also participates in studies of less common but clinically significant immune system diseases, including cutaneous lupus erythematosus, hidradenitis suppurativa, and systemic sclerosis-associated interstitial lung disease. These trials are designed to assess whether new or existing therapies can improve disease activity, reduce inflammation, and provide longer-term safety information.

• Subacute and chronic cutaneous lupus erythematosus
• Hidradenitis suppurativa and related inflammatory skin disease
• Evaluating disease control, safety, and durability of response

The breadth of this research shows a strong commitment to complex immune-mediated conditions that often require specialized care.

In addition to chronic inflammatory disorders, the research portfolio includes studies in other skin and connective tissue diseases such as actinic keratosis and scabies. These trials are aimed at evaluating whether treatments can clear affected skin areas more effectively and improve care for common dermatologic conditions.

• Actinic keratosis of the scalp and face
• Scabies and other treatable skin infestations
• Testing treatment effectiveness and skin clearance

This work broadens the site’s dermatology profile beyond inflammatory disease into preventive and therapeutic skin care research.